Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population

28Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Introduction. Vitamin D deficiency and vitamin D receptor (VDR) gene polymorphism, FokI, is reported to increase the risk of many cancers. Role of vitamin D and its receptor polymorphisms in ovarian cancer has not been clearly defined. Objective. To study the levels of serum vitamin D and occurrence of vitamin D receptor gene polymorphism (FokI) in cases of ovarian cancer. Material and methods. FokI genotyping was done by PCR-RFLP technique and vitamin D levels were estimated by chemiluminescence immunoassay. Results: Serum vitamin D levels were significantly (p < 0.03) lower in ovarian cancer cases as compared to controls. The homozygous (TT) and heterozygous (CT) genotype predispose to the development of ovarian cancer in Indian population (OR: 2.37, 95% CI: 1.04-5.44) as compared to the homozygous (CC) genotype. Vitamin D deficiency and VDR gene polymorphism (FokI) act non-synergistically (p value < 0.4). Conclusion: Low blood levels of vitamin D and VDR receptor polymorphism (FokI) might be a risk factor for the development of ovarian cancer. Other novel ligands of vitamin D receptor might be responsible for the non-synergistic effect. © 2013 Mohapatra et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Mohapatra, S., Saxena, A., Gandhi, G., Koner, B. C., & Ray, P. C. (2013). Vitamin D and VDR gene polymorphism (FokI) in epithelial ovarian cancer in Indian population. Journal of Ovarian Research, 6(1). https://doi.org/10.1186/1757-2215-6-37

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free